AU2002349676A1 - 4-oxoquinoline derivatives - Google Patents
4-oxoquinoline derivativesInfo
- Publication number
- AU2002349676A1 AU2002349676A1 AU2002349676A AU2002349676A AU2002349676A1 AU 2002349676 A1 AU2002349676 A1 AU 2002349676A1 AU 2002349676 A AU2002349676 A AU 2002349676A AU 2002349676 A AU2002349676 A AU 2002349676A AU 2002349676 A1 AU2002349676 A1 AU 2002349676A1
- Authority
- AU
- Australia
- Prior art keywords
- oxoquinoline derivatives
- oxoquinoline
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001-353064 | 2001-11-19 | ||
JP2001353064 | 2001-11-19 | ||
PCT/JP2002/012077 WO2003043992A1 (en) | 2001-11-19 | 2002-11-19 | 4-oxoquinoline derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002349676A1 true AU2002349676A1 (en) | 2003-06-10 |
Family
ID=19165142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002349676A Abandoned AU2002349676A1 (en) | 2001-11-19 | 2002-11-19 | 4-oxoquinoline derivatives |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2002349676A1 (en) |
TW (1) | TW200300349A (en) |
WO (1) | WO2003043992A1 (en) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100074949A1 (en) | 2008-08-13 | 2010-03-25 | William Rowe | Pharmaceutical composition and administration thereof |
KR100665919B1 (en) | 2002-11-20 | 2007-03-08 | 니뽄 다바코 산교 가부시키가이샤 | 4- 4-Oxoquinoline compounds and utilization thereof as HIV integrase inhibitors |
LT2489659T (en) * | 2004-06-24 | 2018-03-26 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
RS60205B1 (en) | 2005-12-28 | 2020-06-30 | Vertex Pharma | Pharmaceutical compositions of the amorphous form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
WO2007102512A1 (en) | 2006-03-06 | 2007-09-13 | Japan Tobacco Inc. | Method for producing 4-oxoquinoline compound |
WO2007102499A1 (en) * | 2006-03-06 | 2007-09-13 | Japan Tobacco Inc. | Process for production of 4-oxoquinoline compound |
ES2536923T3 (en) * | 2006-09-12 | 2015-05-29 | Gilead Sciences, Inc. | Process and intermediates to prepare HIV integrase inhibitors |
AR068403A1 (en) | 2007-09-11 | 2009-11-18 | Gilead Sciences Inc | PROCESS AND INTERMEDIARIES FOR THE PREPARATION OF INTEGRASA INHIBITORS |
KR101955863B1 (en) | 2009-03-20 | 2019-03-07 | 버텍스 파마슈티칼스 인코포레이티드 | Process for making modulators of cystic fibrosis transmembrane conductance regulator |
MX338535B (en) | 2010-11-08 | 2016-04-21 | Albireo Ab | Ibat inhibitors for the treatment of liver diseases. |
NZ629199A (en) | 2012-02-27 | 2017-01-27 | Vertex Pharma | Pharmaceutical compositions comprising a solid dispersion of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
CN104520275B (en) | 2012-08-03 | 2016-11-02 | 吉利德科学公司 | For preparation method and the intermediate product of integrase inhibitor |
KR20220082931A (en) | 2014-06-25 | 2022-06-17 | 이에이 파마 가부시키가이샤 | Solid preparation, and method for preventing or reducing discoloration thereof |
RU2749213C2 (en) | 2014-10-07 | 2021-06-07 | Вертекс Фармасьютикалз Инкорпорейтед | Co-crystals of transmembrane conduction regulator modulators in cystic fibrosis |
AU2016340264B2 (en) | 2015-10-14 | 2021-01-07 | Bristol-Myers Squibb Company | 2,4-dihydroxy-nicotinamides as APJ agonists |
US10441605B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Oral cholestyramine formulation and use thereof |
US10441604B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Cholestyramine pellets and methods for preparation thereof |
US10786529B2 (en) | 2016-02-09 | 2020-09-29 | Albireo Ab | Oral cholestyramine formulation and use thereof |
CN109195963B (en) | 2016-03-24 | 2021-04-23 | 百时美施贵宝公司 | 6-hydroxy-4-oxo-1, 4-dihydropyrimidine-5-carboxamides as APJ agonists |
CA3071285A1 (en) | 2017-08-09 | 2019-02-14 | Albireo Ab | Cholestyramine granules, oral cholestyramine formulations and use thereof |
WO2019234077A1 (en) | 2018-06-05 | 2019-12-12 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
US10793534B2 (en) | 2018-06-05 | 2020-10-06 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
US11801226B2 (en) | 2018-06-20 | 2023-10-31 | Albireo Ab | Pharmaceutical formulation of odevixibat |
AU2019290337B2 (en) | 2018-06-20 | 2023-01-12 | Albireo Ab | Crystal modifications of odevixibat |
US11007142B2 (en) | 2018-08-09 | 2021-05-18 | Albireo Ab | Oral cholestyramine formulation and use thereof |
US10722457B2 (en) | 2018-08-09 | 2020-07-28 | Albireo Ab | Oral cholestyramine formulation and use thereof |
US11549878B2 (en) | 2018-08-09 | 2023-01-10 | Albireo Ab | In vitro method for determining the adsorbing capacity of an insoluble adsorbant |
US10975045B2 (en) | 2019-02-06 | 2021-04-13 | Aibireo AB | Benzothiazepine compounds and their use as bile acid modulators |
US10941127B2 (en) | 2019-02-06 | 2021-03-09 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
EP4069361B1 (en) | 2019-12-04 | 2024-01-03 | Albireo AB | Benzothia(di)azepine compounds and their use as bile acid modulators |
CR20220315A (en) | 2019-12-04 | 2022-10-26 | Albireo Ab | BENZOTI(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS |
US11014898B1 (en) | 2020-12-04 | 2021-05-25 | Albireo Ab | Benzothiazepine compounds and their use as bile acid modulators |
CN114761018A (en) | 2019-12-04 | 2022-07-15 | 阿尔比里奥公司 | Benzothiadiazepine compounds and their use as bile acid modulators |
CA3158276A1 (en) | 2019-12-04 | 2021-06-10 | Per-Goran Gillberg | Benzothia(di)azepine compounds and their use as bile acid modulators |
EP4188541A1 (en) | 2020-08-03 | 2023-06-07 | Albireo AB | Benzothia(di)azepine compounds and their use as bile acid modulators |
JP2023549226A (en) | 2020-11-12 | 2023-11-22 | アルビレオ エービー | Odevixibat for the treatment of progressive familial intrahepatic cholestasis (PFIC) |
BR112023010799A2 (en) | 2020-12-04 | 2023-10-03 | Albireo Ab | BENZOTIA(DI)AZEPINE COMPOUNDS AND THEIR USES AS BILLARY ACID MODULATORS |
TW202404581A (en) | 2022-05-25 | 2024-02-01 | 美商醫肯納腫瘤學公司 | Mek inhibitors and uses thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10130241A (en) * | 1996-10-31 | 1998-05-19 | Wakunaga Pharmaceut Co Ltd | New pyridonecarboxylic acid derivative or its salt and medicine comprising the same |
WO2001034570A1 (en) * | 1999-11-08 | 2001-05-17 | Sankyo Company, Limited | Nitrogenous heterocycle derivatives |
-
2002
- 2002-11-18 TW TW091133622A patent/TW200300349A/en unknown
- 2002-11-19 AU AU2002349676A patent/AU2002349676A1/en not_active Abandoned
- 2002-11-19 WO PCT/JP2002/012077 patent/WO2003043992A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
TW200300349A (en) | 2003-06-01 |
WO2003043992A1 (en) | 2003-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002349676A1 (en) | 4-oxoquinoline derivatives | |
AU2002313565A1 (en) | Putter-heads | |
AU2002363600A1 (en) | Novel phenyl-propargylether derivatives | |
AU2002319532A1 (en) | Feeding-bottles | |
AU2002358715A1 (en) | Tetrahydrobenzfluorene derivatives | |
AU2002226571A1 (en) | Biligands | |
AU2001100406A4 (en) | DriverSMS | |
AU2002313073A1 (en) | Phytocystatin | |
AU2002255269B8 (en) | 2-Iminopyrrolidine derivatives | |
AU2002255269A1 (en) | 2-Iminopyrrolidine derivatives | |
AU2002350425A1 (en) | 6-phenyldihydropyrrolopyrimidinedione derivatives | |
AU2002354530A1 (en) | 4-phenylpyran-2-one derivatives | |
AU2002325368A1 (en) | Benzoylcyclohexenone derivatives | |
AU2002305184A1 (en) | Cycloalkenylsulfonamide derivatives | |
AU2002302578A1 (en) | Amido-diphenyl derivatives | |
AU2002253080A1 (en) | Biurethane derivatives | |
AU2002249205A1 (en) | Bis-triazinylaminobenzoxazole derivatives | |
AU2002230196A1 (en) | Dicarba-closo-dodecarborane derivatives | |
AU2002225034A1 (en) | Rustmicin derivatives | |
AU2002257925A1 (en) | Numberplates | |
AU2002328796A1 (en) | Novel aminoazetidine, -pyrrolidine and -piperidine derivatives | |
AU2002313234A1 (en) | Novel endomorphine derivatives | |
AU2002343546A1 (en) | Beta-carbolin derivatives as ptp-inhibitors | |
AU2001100522A4 (en) | e-Trans | |
AU2001100532A4 (en) | FonePark |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |